Maternal Vitamin D levels and the risk of perinatal death by McGuigan, India et al.
Full Terms & Conditions of access and use can be found at
http://www.tandfonline.com/action/journalInformation?journalCode=ijmf20
Download by: [UQ Library] Date: 15 December 2016, At: 20:08
The Journal of Maternal-Fetal & Neonatal Medicine
ISSN: 1476-7058 (Print) 1476-4954 (Online) Journal homepage: http://www.tandfonline.com/loi/ijmf20
Maternal Vitamin D levels and the risk of perinatal
death
India McGuigan, Christopher Flatley & Sailesh Kumar
To cite this article: India McGuigan, Christopher Flatley & Sailesh Kumar (2016): Maternal
Vitamin D levels and the risk of perinatal death, The Journal of Maternal-Fetal & Neonatal
Medicine, DOI: 10.1080/14767058.2016.1202233
To link to this article:  http://dx.doi.org/10.1080/14767058.2016.1202233
Accepted author version posted online: 16
Jun 2016.
Submit your article to this journal 
Article views: 16
View related articles 
View Crossmark data
Maternal Vitamin D levels and the risk of perinatal death 
 
India McGuigan1, Christopher Flatley1, Sailesh Kumar1, 2 
1Mater Research Institute - University of Queensland, Level 3 Aubigny Place, Raymond 
Terrace, South Brisbane, Queensland 4101, Australia 
2School of Medicine, The University of Queensland, Herston, Queensland, Australia 
 
 
Conflict of interests: The authors report no conflict of interests 
 
Abbreviated title: Vitamin D and perinatal death 
Key Words: Vitamin D, perinatal death, pregnancy, stillbirth 
Word count: 2187 
 
 
Corresponding author and individual responsible for reprint requests: 
Professor Sailesh Kumar 
Mater Research Institute/University of Queensland 
Level 3, Aubigny Place 
Raymond Terrace  
South Brisbane  
Queensland 4101 
Australia 
Tel: +617 3163 8844 
Email: sailesh.kumar@mater.uq.edu.au  JU
ST
 AC
CE
PT
ED
 Abstract 
Objective:  
To determine the association between maternal vitamin D levels and perinatal death. 
 
Methods:  
A retrospective cross-sectional study of all non-anomalous, singleton births (>24 weeks) 
with perinatal death compared to a matched control group. Only pregnancies with a 
recorded vitamin D level at booking (8-19 weeks gestation) were included for analysis. 
Maternal vitamin D levels were categorised into normal, deficient and insufficient cohorts 
and variables compared between the three groups.  
 
Results: 
There were 31 perinatal deaths which were compared to 111 controls. Median vitamin D 
levels were lower in the perinatal death cohort compared to the control group (55nmol/L 
vs. 64nmol/L, p=0.43). There was no significant increase in deaths between the normal and 
deficient (p=0.33) or insufficient (p=0.09) groups. 
 
Conclusions:  
Low maternal vitamin D levels at booking were not associated with an increased risk of 
perinatal demise.  
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Introduction 
Although maternal factors such as advanced maternal age and associated medical co-
morbidities such as pre-eclampsia and diabetes mellitus, pre-term birth and intrauterine 
growth restriction are well known causes of perinatal mortality, many causes still remain 
unknown. [1] There is emerging evidence that Vitamin D is an important factor in fetal 
development, mainly through its role in calcium and phosphate homeostasis and 
subsequent skeletal development. [2, 3]  Vitamin D is important for immunomodulation, cell 
development and differentiation and has most recently been linked to central nervous 
system development.  It has also been implicated in the epigenetic regulation of a 
considerable number of genes. [4] 
 
Vitamin D is primarily synthesized in the skin, a process which requires sunlight, with a 
further small amount obtained through diet. It is metabolised into 25-hydroxy vitamin D, 
the physiologically active form in the liver and then enters the circulation. [3, 5] All fetal 
vitamin D must be obtained from the mother via placental vitamin D transporters. [3] This 
becomes problematic when a mother has low serum vitamin D levels, which is common in 
many nations regardless of socioeconomic status. The prevalence of vitamin D deficiency is 
particularly high in pregnant populations. [6, 7]  In Australia, 25-33% of the general 
population is deficient. [8] During pregnancy, deficiency occurs due to lack of adequate 
sunlight exposure, as well as insufficient oral intake to increase levels to normal [9]. The 
optimal antenatal maternal vitamin D level is not clear, with older reports suggesting that 
levels of >50 nmol/L are adequate. [5]  More recent studies however have revised these cut-
offs and now suggest that serum 25-hydroxy vitamin D levels of >75 nmol/L be classified as 
sufficient or normal, and concentrations of <50 nmol/L be considered deficient. [9] This 
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 revised normal range is believed to be adequate for optimal bone development and 
maintenance and also to regulate placental development and function. [9-11] Adequate 
vitamin D levels are believed to be protective for some adverse fetal outcomes, and are 
associated with greater fetal femur size and higher bone mineral density. [12] Conversely, 
low maternal vitamin D levels have been associated with increased odds of low birth weight, 
preterm birth and reduced fetal bone size and bone mineral density, an increased risk of 
type 1 diabetes mellitus, asthma and schizophrenia. [2, 9, 13]  
 
The association between suboptimal vitamin D levels and perinatal death is not yet well 
characterised. [2] In this study we aimed to determine if perinatal death was increased in 
vitamin D deficient pregnancies and thus if vitamin D deficiency may be a risk factor for this 
perinatal complication.   
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Methods 
This was a retrospective cross sectional study of women with non-anomalous, singleton 
pregnancies who delivered at the Mater Mothers’ Hospital in Brisbane, Australia between 
January 2007 and December 2013. The Mater Mothers’ Hospital is the largest maternity 
hospital in Queensland, with a birth rate of almost 10,000 per annum. The study protocol 
was assessed and approved by the institution’s Human Research Ethics Committee 
(Reference number HREC/14/MHS/37). 
 
Only pregnancies (>24 weeks gestation) with a perinatal death and a documented vitamin D 
level at booking (8-19 weeks gestation) were eligible for inclusion (study cohort). Exclusion 
criteria included multiple births, gestation <24 weeks, known aneuploidy or genetic 
syndromes or termination of pregnancies. Maternal demographic data collected included 
age, body mass index (BMI), ethnicity, parity, mode of delivery, smoking, hypertension/pre-
eclampsia and diabetes mellitus. Perinatal outcomes included gestation at delivery, birth 
weight and fetal or neonatal death. The study cohort was matched for age, BMI and 
ethnicity, smoking and diabetes with a control group of pregnancies for whom booking 
maternal vitamin D levels were also available.  
 
Women were stratified into three groups depending on their serum vitamin D levels. These 
were Normal (>75 nmol/L), Insufficient (50-74 nmol/L) and Deficient (<50 nmol/L). The 
normal vitamin D category was used as the referent group for all comparisons.   
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 Statistical analysis 
Independent samples t-tests were used for comparisons between groups for normally 
distributed continuous variables and the Wilcoxon Rank Sum test was used for skewed 
continuous variables. Proportions for categorical variables were compared using a Chi-
square test or Fisher’s exact test if expected frequencies were <5. All statistical analyses 
were performed using R and the R commander statistical program (R Foundation for 
Statistical Computing, Vienna, Austria). Statistical significance was set at p<0.05. Summary 
statistics are reported as mean (standard deviation) and median (inter-quartile range) as 
appropriate. Odds ratios (OR) and 95% confidence intervals (CI) relative to the Normal 
Vitamin D category were calculated for every other vitamin D category. The Bonferroni 
correction was integrated into continuous data analysis and for categorical variables the 
significance was reset to (p<0.025) as two comparisons were done.  
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Results  
Over the study period there were 31 cases of perinatal death with recorded booking vitamin 
D levels. The control group comprised of 111 women. The median gestation at fetal demise 
was 34 (IQR 27.5-39) weeks with a median birth weight in this cohort of 2320g (IQR 1405.5 – 
2837.5) Although median vitamin D levels were lower in the perinatal death cohort (52.5 
nmol/L vs. 64nmol/L) this difference was not statistically significant. Maternal demographic 
characteristics between the two cohorts are presented in Table 1. 
  
When women were stratified according to Vitamin D level categories (Table 2) there was a 
statistically significant difference in ethnicity and smoking status with less Caucasian women 
in the deficient group in comparison to the normal group. There was also less smokers in 
the deficient group in comparison to the normal group. There were no significant 
differences between the normal and insufficient groups for any variable. (Table 2)  
 
Table 3 details gestation at birth, birth weight and incidence of perinatal demise in the 
various vitamin D categories. The proportion of deaths was highest in the deficient cohort 
compared to the insufficient and normal cohorts (33.3% vs. 11.1% vs. 23.9%, p=0.089). 
There was no significant difference in deaths in either the deficient or insufficient cohorts 
compared to the normal category.  There was no difference in either birthweight or 
birthweight centile or gestation at birth for either of the three categories.  JU
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 Discussion 
The results presented in this paper demonstrate that maternal vitamin D levels are not 
significantly reduced in pregnancies with fetal or neonatal demise. Our results suggest that 
vitamin D insufficiency or deficiency is not necessarily associated with  perinatal death albeit 
the highest number of deaths were observed in the deficiency group.  
 
There is limited published literature on the impact of maternal vitamin D deficiency and 
death. In a Tanzanian study, Mehta et al. (2009) found that children of vitamin D deficient 
mothers had a 49% increased risk of dying in the 2 years after birth with children born to the 
most vitamin D deficient mothers having the greatest risk of death. Confounding factors of 
this particular study however, was the high rate of HIV-positivity of the entire study cohort 
[14].  
 
How vitamin D deficiency is a causative factor for fetal or neonatal death is currently 
unknown.  There is evidence that vitamin D deficiency is associated with pancreatic β cell 
dysfunction and insulin resistance. [15, 16]  Furthermore, it appears that insulin secretion is 
impaired in the vitamin D-deficient pancreas, and vitamin D repletion improves this. [17, 18] 
As glucose is the main energy substrate for intrauterine growth, disruption of normal 
glucose homeostasis in pregnancy predisposes to perturbations in fetal growth and hence 
could possibly increase the risk of perinatal death. 
 
Very few studies have investigated the effect of maternal vitamin D levels on fetal or 
neonatal death, with some studies [19] indicating no association between the two. 
Regardless of the negative result of this study, vitamin D is still believed to play a significant 
JU
ST
AC
CE
PT
ED
role in fetal development. As it is difficult for newborns to rely purely on breast milk for 
vitamin D, it is important that pregnant women are nutritionally replete to ensure healthy 
fetal development. [8]  Hypocalcaemia and rickets are severe malformations commonly 
associated with vitamin D deficiency, but it has also been linked to a number of other 
adverse outcomes, including low birth weight, pre-term birth and skeletal mineral 
deficiencies. [2, 20] These outcomes result from the role of vitamin D in immunomodulation 
and cellular proliferation and differentiation in the musculoskeletal and central nervous 
systems. [21] Therefore, low maternal vitamin D level is likely to directly impact skeletal 
structure, bone mass and physiology of the newborn. [8] In contrast maternal vitamin D 
levels above 75 nmol/L have been associated with higher fetal femur volume and bone 
mineral density, indicating a protective role for the developing skeleton. [21]  Maternal 
vitamin D deficiency in the third trimester is a significant risk factor for congenital rickets. [3, 
20] The rate of mortality is forty times greater in small-for-gestational-age and pre-term 
newborns in comparison to those with normal birth weight and gestation, thus if vitamin D 
deficiency limits growth capacity, it may thus increase the risk of fetal, neonatal or longer 
term  death. [1, 13, 22] 
 
Vitamin D deficiency has also been linked with prematurity, another risk factor for perinatal 
death. Suboptimal levels can reduce blood calcium, increasing bone turnover and 
decreasing bone mineral accumulation, which limits the growth trajectory of the developing 
fetus. [2, 23]  Preterm birth and low birth weight are linked to compromised skeletal 
development and nutrient transport as calcium accumulation and mineralization occurs 
mostly in third trimester. [2, 24, 25]  Genuis [26] reported that vitamin D deficient mothers 
were 2.4 times more likely to give birth to small-for-gestational-age infants. 
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 Adequate maternal stores early in pregnancy are critical as it appears that vitamin D 
supplementation in the third trimester does not appear to adequately increase vitamin D 
levels into the normal range. [25]  Although maximal fetal growth occurs in the third 
trimester,  the growth trajectory is determined earlier in pregnancy and thus it is likely that 
unless normal levels of vitamin D are present early in development, impaired growth is likely 
to occur. [2, 25]  In our study, the median birth weight centile was lowest in the deficient 
group suggesting some degree of growth restriction which may have contributed to the 
increased rate of perinatal death observed. Intrauterine growth restriction and pre-term 
birth are common causes of fetal or neonatal death, with either factor increasing the risk of 
mortality up to forty times [13, 23]. There is also evidence that in an animal model, the 
effects of placental hypoxia ischemia are reduced by maternal vitamin D supplementation. 
[27] It may be plausible that a similar mechanism could potentially function in humans. 
 
Our study is limited by its sample size and the fact that maternal vitamin D levels were not 
routinely measured at the Mater Hospital over the study period limiting the number of 
cases who met the study criteria. This is potentially a source of bias as maternal vitamin D 
levels may have only been checked because the treating clinician had a particular clinical 
concern which may have thus skewed the results. There were also many pregnancies 
resulting in death with no recorded maternal vitamin D data, which may have skewed the 
result towards no effect. It is also entirely possible that there is no link between vitamin D 
levels and fetal death, as other studies have previously suggested. [19]   
 
Although our study did not show any significant association between vitamin D deficiency 
and perinatal death the highest proportion of deaths was seen in the deficient cohort and 
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further studies with larger sample sizes are required to more accurately determine any 
relationship between. . Vitamin D supplements are affordable, readily available and very 
safe and have been shown to benefit maternal and fetal health [5]. The current prescribed 
400 IU/day for pregnant women is insufficient to correct low levels of maternal vitamin D, 
with recent studies suggesting 4000 IU/day is safe and is necessary to correct suboptimal 
maternal levels. Consequently, it would be beneficial and reasonable for vitamin D 
insufficient and deficient pregnant women to consume 4000 IU/day regardless of the impact 
of vitamin D on perinatal death [28]. The relationship between maternal vitamin D levels, 
impaired fetal growth and fetal demise is likely to be complex with no one causal pathway. 
Nevertheless the results presented in our study warrants further investigation. 
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 Table 1: Maternal demographics  
  Control cohort Fetal death cohort  p value  
n=111  n=31    
Age
~
 31.64 (4.93) 31.00 (5.51) 0.56 
BMI^ 23.50 (20.96-27.38) 24.01 (21.62-25.86) 0.90 
Ethnicity        
   Caucasian 64 (57.7) 15 (48.4) 0.36 
   Indigenous (ATSI) 3 (2.7) 1 (3.2) 1.00 
   Asian 16 (14.4) 3 (9.7) 0.77 
  Indian 8 (7.2) 2 (6.5) 1.00 
   Other 20 (18.0) 10 (32.3) 0.09 
Parity       
  P0 62 (55.9) 13 (41.9) 0.17 
  P1 38 (34.2) 10 (32.3) 0.84 
  P2 6 (5.4) 1 (3.2) 1.00 
 >P3 5 (4.5) 7 (22.6) 0.004* 
Hypertension (including PET) 5 (4.5) 5 (16.1) 0.04* 
Smoking 19 (17) 2 (6.7) 0.57 
Diabetes 8 (7.1) 1 (3.3) 0.68 
Vitamin D (nmol/L)^ 64.0 (49.5-80.0) 55.0 (40.0-84.0) 0.43 
  Normal^ 90.0 (81.0-109.0) 96.0 (84.0-100.0) 0.88 
  Insufficiency^ 60.5 (52.0-70.0) 65.0 (56.3-71.5) 0.45 
  Deficiency^ 40.0 (30.0-45.0) 38.0 (32.3.5-44.3) 0.79 
Birthweight^ 3420.5 (3064.0-3686.0) 2320.0 (1405.5-2837.5) <0.0001* 
Birthweight centile^ 63.3 (43.2-79.4) 23.3 (15.3-34.8) <0.0001* 
 
BMI: body mass index, PET: Pre-eclampsia, ATSI: Aboriginal and Torres Straits Islander 
Data presented as Number (percentage) unless stated otherwise 
^Data presented as Median (interquartile range) 
~Data presented as Mean (standard deviation) 
*Indicates a statistically significant result (p<0.05) 
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Table 2: Maternal Demographics according to Vitamin D category 
 
 Deficient 
(<50nmol/L) 
n= 42 
Insufficient (50-
74nmol/L) 
n=54 
Normal  
(>/75nmol/L) 
n=46 
Normal vs 
Deficient 
p value 
Normal vs 
Insufficient 
p value 
Age
~
 31.07 (5.48) 32.59 (4.65) 30.61 (4.96) 1.00 0.15 
BMI^ 24.0 (22.6-
24.7) 
23.9 (21.4-27.1) 23.5 (21.0-27.5) 1.00 1.00 
Ethnicity            
   Caucasian 11 (26.2) 38 (70.4) 30 (65.2) <0.0001* 0.667 
   Indigenous 
(ATSI) 
0 (0.0) 2 (3.7) 2 (4.3) 0.4953 1.00 
   Asian 8 (19.0) 5 (9.3) 6 (13.0) 0.592 0.364 
   Indian 4 (9.5) 5 (7.4) 1 (2.2) 0.367 0.214 
   Other 19 (45.2) 4 (7.4) 7 (15.2) 0.002* 0.214 
Parity           
P0 22 (52.4) 33 (61.1) 20 (43.5) 0.435 0.223 
P1 14 (33.3) 15 (27.8) 19 (41.3) 0.621 0.155 
P2 1 (2.4) 2 (3.7) 4 (8.7) 0.201 0.410 
P3+ 5 (11.9) 4 (7.4) 3 (6.5) 0.380 1.00 
Hypertension 
(including PET) 
2 (4.8) 4 (7.4) 4 (8.7) 0.678 1.00 
Smoking 2 (4.8) 8 (14.8) 11 (23.9) 0.015* 0.248 
Diabetes 3 (7.1) 3 (5.6) 3 (6.5) 1.00 1.00 
 
 
BMI: body mass index, PET: Pre-eclampsia, ATSI: Aboriginal and Torres Straits Islander 
Data presented as Number (percentage) unless stated otherwise 
^Data presented as Median (interquartile range) 
~ Data presented as Mean (standard deviation 
*Indicates a statistically significant result (p<0.05), Bonferroni correction was applied for continuous variables, 
setting significance at (p<0.025) 
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 Table 3: Fetal outcomes by Vitamin D category.  
  Deficiency 
(<50nmol/L) 
n= 42 
Insufficiency 
(50-74nmol/L) 
n=54 
Normal Vitamin 
D  
(>/75nmol/L) 
n=46 
Normal vs 
Deficiency 
p value   
Normal vs 
Insufficiency 
p value   
Gestation at 
delivery 
(weeks)
^ 
36 (34-39) 38 (37-39) 39 (37.8-40) 1.00 0.104 
Birth weight
^
 3086 (2454.5-
3429.0) 
3441 (3108.25-
3737.0) 
3170 (2642.0-
3527.5) 
1.00 0.055 
Birth weight 
centile^ 
0.45 (0.25-0.64) 0.65 (0.45-0.81) 0.49 (0.29-0.71) 0.800 0.084 
Death  14 (33.3)  6 (11.1)   11 (23.9) 0.328 0.089  
 
BMI: body mass index, PET: Pre-eclampsia, ATSI: Aboriginal and Torres Straits Islander 
Data presented as Number (percentage) unless stated otherwise 
^Data presented as Median (interquartile range) 
~ Data presented as Mean (standard deviation 
*Indicates a statistically significant result (p<0.05), Bonferroni correction was applied for continuous variables, 
setting significance at (p<0.025) 
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